CELLARX
DEAD

Serial Number

97792405

Owner

Cellarity, Inc.

Attorney

Christina M. Licursi

Filing Date

Feb 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CELLARX Trademark

Serial Number: 97792405

CELLARX is a trademark filed by Cellarity, Inc. on February 13, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Cellarity, Inc. (24 trademarks)

Somerville, MA 02143

Entity Type: 03

Trademark Details

Filing Date

February 13, 2023

Registration Date

Not Registered

Goods & Services

Pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders

Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; drug development and discovery; scientific research in the field of drug discovery and development; biomedical research services; preclinical development of therapeutic products; bioinformatic services for scientific research purposes, namely, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combatting of diseases; scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and research relating to drug development; software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 21, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 21, 2024 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 1, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 1, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 3, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 3, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 3, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 21, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 2, 2023 NWOS
NEW APPLICATION ENTERED
Feb 16, 2023 NWAP